Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes.

Autor: Cecchini M; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Walther Z; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Sklar JL; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Bindra RS; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA., Petrylak DP; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Eder JP; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Goldberg SB; Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA. Electronic address: sarah.goldberg@yale.edu.
Jazyk: angličtina
Zdroj: The Lancet. Oncology [Lancet Oncol] 2018 Jan; Vol. 19 (1), pp. 23-24.
DOI: 10.1016/S1470-2045(17)30916-6
Databáze: MEDLINE